DV
Dividend Vision

EBS — Emergent Biosolutions Inc

Emergent Biosolutions Inc (EBS)

Total return is -55.9% over the past 19.7 years, 753.1 points behind SPY at 697.2%. Its deepest 1-year drawdown was 68.0%.

Emergent Biosolutions Inc is an equity stock representing a single company in the biotechnology and life sciences sector. The fund has no distribution yield or regular dividend payments, making it unsuitable for income-focused investors. It appeals primarily to growth-oriented investors seeking exposure to a specialized biopharmaceutical company rather than those pursuing dividend income strategies.

EBS key facts

Asset type
Stock
Asset class
Equity
Inception date
11/15/2006
Last close
$4.59
Market cap
$393,679,744
Average volume
1094400.0
Last dividend
$1.8550
Beta
2.339
Payout ratio
0.0
Forward P/E
2.0773
EPS
$-0.19